Peregrine Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-153,810
| Closed | -$13.8M | – | 325 |
|
|
2020
Q1 | $13.8M | Buy |
153,810
+1,196
| +0.8% | +$107K | 0.5% | 77 |
|
|
2019
Q4 | $16.5M | Buy |
152,614
+587
| +0.4% | +$63.5K | 0.42% | 109 |
|
|
2019
Q3 | $14.9M | Sell |
152,027
-13,859
| -8% | -$1.36M | 0.41% | 112 |
|
|
2019
Q2 | $21.7M | Hold |
165,886
| – | – | 0.54% | 65 |
|
|
2019
Q1 | $22.4M | Buy |
165,886
+1,963
| +1% | +$265K | 0.56% | 54 |
|
|
2018
Q4 | $16M | Buy |
163,923
+14,315
| +10% | +$1.39M | 0.45% | 88 |
|
|
2018
Q3 | $20.8M | Hold |
149,608
| – | – | 0.49% | 83 |
|
|
2018
Q2 | $18.6M | Buy |
149,608
+457
| +0.3% | +$56.7K | 0.46% | 89 |
|
|
2018
Q1 | $16.6M | Buy |
149,151
+22,831
| +18% | +$2.54M | 0.41% | 102 |
|
|
2017
Q4 | $15.1M | Buy |
126,320
+28,900
| +30% | +$3.46M | 0.36% | 115 |
|
|
2017
Q3 | $13.7M | Hold |
97,420
| – | – | 0.33% | 124 |
|
|
2017
Q2 | $11.9M | Buy |
97,420
+19,427
| +25% | +$2.36M | 0.3% | 141 |
|
|
2017
Q1 | $9.42M | Sell |
77,993
-38,854
| -33% | -$4.69M | 0.24% | 179 |
|
|
2016
Q4 | $14.3M | Hold |
116,847
| – | – | 0.37% | 108 |
|
|
2016
Q3 | $14.3M | Buy |
+116,847
| New | +$14.3M | 0.37% | 110 |
|